Elan Corporation PLC Names Robert A. Ingram Chairman-Designate

DUBLIN--(BUSINESS WIRE)--Elan Corporation, plc ("Elan") (NYSE: ELN) today announced that the Company’s Board of Directors has appointed Robert A. Ingram, former Chief Executive Officer of Glaxo Wellcome plc and former Vice Chairman Pharmaceuticals of GlaxoSmithKline, to the Board effective immediately. Further, he will assume his role as Chairman effective January 26, 2011, the date of the next board meeting, and will at that time succeed Kyran McLaughlin, who in April announced his intention to step down as Non-Executive Chairman following the completion of a search for a successor.

Back to news